Download PDF
Semin Thromb Hemost 2011; 37(3): 193-198
DOI: 10.1055/s-0031-1273083
© Thieme Medical Publishers

Gender and the Risk of Venous Thromboembolism

Daniela Tormene1 , Valeria Ferri1 , Sara Carraro1 , Paolo Simioni1
  • 1Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Padua, Italy
Further Information

Publication History

Publication Date:
31 March 2011 (online)

    Permissions and Reprints

ABSTRACT

The role of gender in the causation of first and recurrent venous thromboembolism (VTE) is uncertain. The use of hormonal therapy and pregnancy has been associated with VTE in women. Epidemiological studies have described a higher incidence of first VTE in women of childbearing age. Nevertheless, no consistent differences in the overall incidence of VTE between males and females have been found. Recent studies have shown that women exhibit a lower risk of recurrent VTE than men, although these data were not confirmed in other studies that evaluated only women with idiopathic VTE. This article reviews the role of gender as a risk factor for first and recurrent VTE.

KEYWORDS

Venous thromboembolism - gender - ethnicity

REFERENCES

  • 1 Silverstein M D, Heit J A, Mohr D N, Petterson T M, O'Fallon W M, Melton III L J. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.  Arch Intern Med. 1998;  158 (6) 585-593
    CrossrefPubMedGoogle Scholar
  • 2 Kyrle P A, Eichinger S. Deep vein thrombosis.  Lancet. 2005;  365 (9465) 1163-1174
    CrossrefPubMedGoogle Scholar
  • 3 Anderson Jr F A, Wheeler H B, Goldberg R J et al.. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.  Arch Intern Med. 1991;  151 (5) 933-938
    CrossrefPubMedGoogle Scholar
  • 4 Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population.  J Intern Med. 1992;  232 (2) 155-160
    CrossrefPubMedGoogle Scholar
  • 5 Prandoni P, Lensing A W, Cogo A et al.. The long-term clinical course of acute deep venous thrombosis.  Ann Intern Med. 1996;  125 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 6 Heit J A, Mohr D N, Silverstein M D, Petterson T M, O'Fallon W M, Melton III L J. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.  Arch Intern Med. 2000;  160 (6) 761-768
    CrossrefPubMedGoogle Scholar
  • 7 Heit J A, Melton III L J, Lohse C M et al.. Incidence of venous thromboembolism in hospitalized patients vs community residents.  Mayo Clin Proc. 2001;  76 (11) 1102-1110
    CrossrefPubMedGoogle Scholar
  • 8 Spencer F A, Emery C, Lessard D et al.. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism.  J Gen Intern Med. 2006;  21 (7) 722-727
    CrossrefPubMedGoogle Scholar
  • 9 White R H, Zhou H, Romano P S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.  Ann Intern Med. 1998;  128 (9) 737-740
    CrossrefPubMedGoogle Scholar
  • 10 White R H, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996.  Thromb Haemost. 2005;  93 (2) 298-305
    PubMedGoogle Scholar
  • 11 Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan.  J Thromb Haemost. 2006;  4 (3) 581-586
    CrossrefPubMedGoogle Scholar
  • 12 Samama M M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.  Arch Intern Med. 2000;  160 (22) 3415-3420
    CrossrefPubMedGoogle Scholar
  • 13 Danilenko-Dixon D R, Heit J A, Silverstein M D et al.. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study.  Am J Obstet Gynecol. 2001;  184 (2) 104-110
    CrossrefPubMedGoogle Scholar
  • 14 Gomes M P, Deitcher S R. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.  Arch Intern Med. 2004;  164 (18) 1965-1976
    CrossrefPubMedGoogle Scholar
  • 15 Rosendaal F R. Risk factors for venous thrombotic disease.  Thromb Haemost. 1999;  82 (2) 610-619
    PubMedGoogle Scholar
  • 16 Kemmeren J M, Algra A, Grobbee D E. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.  BMJ. 2001;  323 (7305) 131-134
    CrossrefPubMedGoogle Scholar
  • 17 Grady D, Wenger N K, Herrington D et al.. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.  Ann Intern Med. 2000;  132 (9) 689-696
    PubMedGoogle Scholar
  • 18 Smith N L, Heckbert S R, Lemaitre R N et al.. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.  JAMA. 2004;  292 (13) 1581-1587
    CrossrefPubMedGoogle Scholar
  • 19 Kawase K, Okazaki S, Toyoda K et al.. Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage.  Cerebrovasc Dis. 2009;  27 (4) 313-319
    CrossrefPubMedGoogle Scholar
  • 20 Cushman M, Tsai A, Heckbert S R et al.. Incidence rates, case fatality, and recurrence rates of deep vein thrombosis and pulmonary embolus: the Longitudinal Investigation of Thromboembolism Etiology (LITE) [abstract].  Thromb Haemost. 2001;  86 (Suppl 1) OC2349
    PubMedGoogle Scholar
  • 21 Kniffin Jr W D, Baron J A, Barrett J, Birkmeyer J D, Anderson Jr F A. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.  Arch Intern Med. 1994;  154 (8) 861-866
    CrossrefPubMedGoogle Scholar
  • 22 Andreou E R, Koru-Sengul T, Linkins L, Bates S M, Ginsberg J S, Kearon C. Differences in clinical presentation of deep vein thrombosis in men and women.  J Thromb Haemost. 2008;  6 (10) 1713-1719
    CrossrefPubMedGoogle Scholar
  • 23 Bauersachs R M, Riess H, Hach-Wunderle V et al.. Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis.  Thromb Haemost. 2010;  103 (4) 710-717
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Robert-Ebadi H, Le Gal G, Carrier M et al.. Differences in clinical presentation of pulmonary embolism in women and men.  J Thromb Haemost. 2010;  8 (4) 693-698
    CrossrefPubMedGoogle Scholar
  • 25 Tormene D, Barbar S, Perlati M, Brandolin B, Simioni P. Sex-related type of venous thromboembolism in patients with and without thrombophilia.  Thromb Haemost. 2009;  102 (1) 177-178
    PubMedGoogle Scholar
  • 26 Heit J A, Mohr D N, Silverstein M D, Petterson T M, O'Fallon W M, Melton III L J. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.  Arch Intern Med. 2000;  160 (6) 761-768
    CrossrefPubMedGoogle Scholar
  • 27 Kyrle P A, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women.  N Engl J Med. 2004;  350 (25) 2558-2563
    CrossrefPubMedGoogle Scholar
  • 28 Baglin T, Luddington R, Brown K, Baglin C. High risk of recurrent venous thromboembolism in men.  J Thromb Haemost. 2004;  2 (12) 2152-2155
    CrossrefPubMedGoogle Scholar
  • 29 Agnelli G, Becattini C, Prandoni P. Recurrent venous thromboembolism in men and women.  N Engl J Med. 2004;  351 (19) 2015-2018; author reply 2015–2018
    CrossrefPubMedGoogle Scholar
  • 30 Prandoni P, Noventa F, Ghirarduzzi A et al.. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.  Haematologica. 2007;  92 (2) 199-205
    CrossrefPubMedGoogle Scholar
  • 31 Cushman M, Glynn R J, Goldhaber S Z et al.. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial.  J Thromb Haemost. 2006;  4 (10) 2199-2203
    CrossrefPubMedGoogle Scholar
  • 32 Eriksson H, Lundström T, Wåhlander K, Clason S B, Schulman S. THRIVE III Investigators . Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.  Thromb Haemost. 2005;  94 (3) 522-527
    PubMedGoogle Scholar
  • 33 McRae S, Tran H, Schulman S, Ginsberg J, Kearon C. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.  Lancet. 2006;  368 (9533) 371-378
    CrossrefPubMedGoogle Scholar
  • 34 Eichinger S, Heinze G, Jandeck L M, Kyrle P A. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.  Circulation. 2010;  121 (14) 1630-1636
    CrossrefPubMedGoogle Scholar
  • 35 Lijfering W M, Veeger N J, Middeldorp S et al.. A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families.  Blood. 2009;  114 (10) 2031-2036
    CrossrefPubMedGoogle Scholar

Daniela TormeneM.D. Ph.D. 

Department of Cardiologic, Thoracic and Vascular Sciences, Thromboembolism Unit, University of Padua

Via Giustiniani 2, 35128 Padua, Italy

Email: daniela.tormene@unipd.it

      >